Jesmina Rexha

Dr. Jesmina Rexha

Marche Polytechnic University, Ancona, Marche, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
ARAlice Romagnoli
Alice Romagnoli
PMPaolo Moretti
Paolo Moretti
MDMattia D’agostino
Mattia D’agostino
JRJesmina Rexha
Jesmina Rexha
Nunzio PertaNunzio Perta
Nunzio Perta
ATAnna La Teana
Anna La Teana
The translation factor IF5A is a highly conserved protein playing a well-recognized and well-characterized role in protein synthesis; nevertheless, some of its features as well as its abundance in the cell suggest that it may perform additional functions related to RNA metabolism. Here, we have undertaken a structural and functional characterization of aIF5A from the crenarchaeal Sulfolobus solfataricus model organism. We confirm the association of aIF5A with several RNA molecules in vivo and demonstrate that the protein is endowed with a ribonuclease activity which is specific for long and structured RNA. By means of biochemical and structural approaches we show that aIF5A can exist in both monomeric and dimeric conformations and the monomer formation is favored by the association with RNA. Finally, modelling of the three-dimensional structure of S. solfataricus aIF5A shows an extended positively charged surface which may explain its strong tendency to associate to RNA in vivo.

23 December 2025 in bioRxiv
Verified
Preprint
Open access
ARAgnese Roscioni
Agnese Roscioni
VDVincenzo Maria D'Amore
Vincenzo Maria D'Amore
JRJesmina Rexha
Jesmina Rexha
GBGreta R. Bianchini
Greta R. Bianchini
ATAnna La Teana
Anna La Teana
FLFrancesco Saverio Di Leva
Francesco Saverio Di Leva
The eukaryotic initiation factor 4E (eIF4E) governs cap-dependent translation and its dysregulation contributes both to cancer and neurological disorders, making it an attractive target for therapeutic intervention. Among the few small-molecule inhibitors developed, 4EGI-1 and its analogue i4EG-BiP have shown promise in cellular and preclinical models. These compounds disrupt eIF4E binding to its partner eIF4G while enhancing association with its negative regulators, the 4E-BPs. Despite their chemical similarity and overlapping functional effects, structural data suggest the two ligands engage different regions of eIF4E, lateral for 4EGI-1 and frontal for i4EG-BiP, raising questions about the basis of their shared activity. Here, we integrate molecular simulations, site-directed mutagenesis, and fluorescence binding assays to elucidate the binding mechanism of both ligands. Molecular dynamics and binding experiments on mutants reveal largely consistent interaction patterns, while funnel metadynamics free-energy calculations indicate that the frontal binding mode is thermodynamically preferred for both compounds. Strikingly, we demonstrate that the conformational rearrangement induced by frontal binding selectively promotes 4E-BP1 over eIF4G association, owing to the greater plasticity of the 4E-BP1 binding motif. These findings reconcile divergent structural observations and highlight how ligand-induced dynamics can be exploited to reprogram eIF4E interactions, offering a framework for next-generation therapeutics targeting dysregulated translation.